Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Korean Government Fines Five Pharma Multinationals For Unfair Trade

This article was originally published in PharmAsia News

Executive Summary

SEOUL - South Korea's trade watchdog, the Fair Trade Commission, has imposed fines collectively totaling KRW 20.48 billion ($14.8 million) on seven pharmaceutical companies - including five multinationals - on charges of unfair provision of rebates and other improper benefits to doctors and hospitals

You may also be interested in...



Korea's Antitrust Watchdog Says Rebates Continuing Despite New Law; Levies $11 Million In Fines

SEOUL - South Korea's antitrust watchdog the Fair Trade Commission said rebates by both multinational and local Korean pharmaceutical companies are continuing even though doctors can be punished for accepting rebates under a new law that took effect late last year

Korea's Antitrust Watchdog Says Rebates Continuing Despite New Law; Levies $11 Million In Fines

SEOUL - South Korea's antitrust watchdog the Fair Trade Commission said rebates by both multinational and local Korean pharmaceutical companies are continuing even though doctors can be punished for accepting rebates under a new law that took effect late last year

Four Major South Korean Hospitals Are Penalized For Soliciting "Donations" From Pharmaceutical Outfits Including MNCs

SEOUL - In the latest government action against irregular business deals in the medical sector, South Korea's Fair Trade Commission has imposed penalties amounting to KRW550 million (about $484,282) on the country's four leading general hospitals for receiving "donations" from 14 local and international pharmaceutical firms to fund expansion projects

Related Content

UsernamePublicRestriction

Register

SC069852

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel